scholarly article | Q13442814 |
P356 | DOI | 10.1021/JO00198A026 |
P5875 | ResearchGate publication ID | 231576754 |
P2093 | author name string | Masato Koreeda | |
William M. Butler | |||
Ara G. Paul | |||
George M. Hatfield | |||
Leander J. Valdes | |||
P433 | issue | 24 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | salvinorin B | Q9333044 |
Salvia divinorum | Q320584 | ||
salvinorin A | Q413512 | ||
terpenoids | Q426694 | ||
P304 | page(s) | 4716-4720 | |
P577 | publication date | 1984-11-01 | |
P1433 | published in | Journal of Organic Chemistry | Q898967 |
P1476 | title | Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint, Salvia divinorum | |
P478 | volume | 49 |
Q33719556 | A (-)-kolavenyl diphosphate synthase catalyzes the first step of salvinorin A biosynthesis in Salvia divinorum. |
Q33973923 | Acute Physiologic and Chronic Histologic Changes in Rats and Mice Exposed to the Unique Hallucinogen Salvinorin A |
Q38902043 | Clerodane diterpenes: sources, structures, and biological activities |
Q28275440 | Collybolide is a novel biased agonist of κ-opioid receptors with potent antipruritic activity |
Q47871946 | Depressant Effects of Salvia divinorum Involve Disruption of Physiological Sleep. |
Q104391140 | High performance liquid chromatographic quantification of salvinorin a from tissues ofsalvia divinorum epling & játiva-m |
Q36894509 | Immediate and Persistent Effects of Salvinorin A on the Kappa Opioid Receptor in Rodents, Monitored In Vivo with PET. |
Q36977483 | Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors. |
Q34714459 | Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial |
Q38778876 | Molecular Signaling Pathways Behind the Biological Effects of Salvia Species Diterpenes in Neuropharmacology and Cardiology |
Q27300685 | Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans |
Q37777404 | Natural Products from the Hallucinogenic Sage |
Q105149391 | Neo-clerodane diterpenoids from Salvia madrensis |
Q37660087 | New therapeutic potential for psychoactive natural products |
Q42286399 | Novel neoclerodane diterpene derivatives from the smoke of salvinorin A |
Q35840042 | Potential Drug Abuse Therapeutics Derived from the Hallucinogenic Natural Product Salvinorin A |
Q40585107 | Salvia divinorum and the unique diterpene hallucinogen, Salvinorin (divinorin) A. |
Q44641835 | Salvia divinorum use and phenomenology: results from an online survey |
Q33913584 | Salvia divinorum: an hallucinogenic mint which might become a new recreational drug in Switzerland. |
Q57888900 | Salvia divinorum: toxicological aspects and analysis in human biological specimens |
Q24535736 | Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist |
Q35082154 | Salvinorin A: the "magic mint" hallucinogen finds a molecular target in the kappa opioid receptor |
Q46333990 | Screening of Hallucinogenic Compounds and Genomic Characterisation of 40 Anatolian Salvia Species. |
Q38976907 | Silver & gold-catalyzed routes to furans and benzofurans. |
Q35887833 | Synthesis and biological evaluation of C-2 halogenated analogs of salvinorin A |
Q24681800 | Synthetic studies of neoclerodane diterpenes from Salvia divinorum: exploration of the 1-position |
Q48248296 | Total Synthesis of (-)-Salvinorin A. |
Q79919819 | Unambiguous NMR spectral assignments of salvinorin A |
Q37855806 | Utilizing nature as a source of new probes for opioid pharmacology |
Search more.